Abstract:One of the major applications of generative models for drug discovery targets the lead-optimization phase. During the optimization of a lead series, it is common to have scaffold constraints imposed on the structure of the molecules designed. Without enforcing such constraints, the probability of generating molecules with the required scaffold is extremely low and hinders the practicality of generative models for de novo drug design. To tackle this issue, we introduce a new algorithm, named SAMOA (Scaffold Constrained Molecular Generation), to perform scaffold-constrained in silico molecular design. We build on the well-known SMILES-based Recurrent Neural Network (RNN) generative model, with a modified sampling procedure to achieve scaffold-constrained generation. We directly benefit from the associated reinforcement learning methods, allowing to design molecules optimized for different properties while exploring only the relevant chemical space. We showcase the method's ability to perform scaffold-constrained generation on various tasks: designing novel molecules around scaffolds extracted from SureChEMBL chemical series, generating novel active molecules on the Dopamine Receptor D2 (DRD2) target, and finally, designing predicted actives on the MMP-12 series, an industrial lead-optimization project.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jcim.0c01015?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jcim.0c01015</a>.Availability of data used to train models and run experiments, algorithmic description of naive policy masking (Algorithm S1), algorithmic description of hill-climbing (Algorithm S2), examples of molecules obtained after sampling the core of fexofenadine (Figure S1 for sampled molecules, Figure S2 for the original molecule), examples of molecules obtained after replacing the ring system of fexofenadine (Figure S3), distributions of ClogP, Molecular Weight, QED and SAS for reference molecules, molecules where a branched decoration was sampled, and molecules where the core was sampled (Figure S4), the 17 validation scaffolds from SureChEMBL (Figure S5), histograms of Tanimoto similarities between generated molecules for each of the DRD2 scaffolds (Figure S6), and unicity of sampled decorations for each open positions of the DRD2 scaffolds (Figure S7) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.0c01015/suppl_file/ci0c01015_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Scaffold-Hopping from Synthetic Drugs by Holistic Molecular Representation

Molecular Scaffold Hopping via Holistic Molecular Representation

Scaffold-Hopped Compound Identification by Ligand-Based Approaches with a Prospective Affinity Test

“Molecular Anatomy”: a new multi-dimensional hierarchical scaffold analysis tool

Scaffold Hopping of Potential Anti-Tumor Agents by WEGA: a Shape-Based Approach

Deep Scaffold Hopping with Multi-modal Transformer Neural Networks

Scaffold hopping approaches for dual-target antitumor drug discovery: opportunities and challenges

SynthFormer: Equivariant Pharmacophore-based Generation of Molecules for Ligand-Based Drug Design

Scaffold Hopping with Generative Reinforcement Learning

Scaffold-Constrained Molecular Generation

Bioisosteric Replacement and Scaffold Hopping in Lead Generation and Optimization

DrugEx V3: Scaffold-Constrained Drug Design with Graph Transformer-Based Reinforcement Learning

DiffHopp: A Graph Diffusion Model for Novel Drug Design via Scaffold Hopping

Scaffold hopping by net photochemical carbon deletion of azaarenes

Abstract Wrk2-04: Virtual screening of ultra-large chemical spaces for novel chemotype discovery

On Scaffolds and Hopping in Medicinal Chemistry

Accelerating Discovery of Novel and Bioactive Ligands With Pharmacophore-Informed Generative Models

DrugHIVE: Target-specific spatial drug design and optimization with a hierarchical generative model

DeepScaffold: A Comprehensive Tool for Scaffold-Based De Novo Drug Discovery Using Deep Learning

SMILES-based deep generative scaffold decorator for de-novo drug design

Scaffold-Based Multi-Objective Drug Candidate Optimization